Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nouscom logo — company profile

Nouscom

Founded 2015 Switzerland Switzerland 57 employees Series C Total: $128.50M Biotechnology, Health Care +1

General Information

Company Name Nouscom
Founded Year 2015
Location Switzerland Switzerland +1
Employees 57
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series C
Social

Get notified when Nouscom moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nouscom

Nouscom is a biotech startup founded in 2015 and headquartered in Switzerland. The company is focused on developing highly effective immunotherapeutics targeting cancerous cells. Its last funding round, a €75.80M Series C investment on 21 March 2024, saw participation from a diverse group of investors including Bpifrance, 5AM Ventures, Life Science Partners, Versant Ventures, Andera Partner, Indaco Venture Partners, MERL Ventures Fund, Panakes Partners, Revelation Partners, and XGEN Venture. Nouscom operates in the biotechnology and health care industries, and its innovative approach to immunotherapy positions the company at the forefront of the fight against cancer.

Taxonomy: biotech, startup, immunotherapeutics, cancer treatment, oncology, biomedical, biopharmaceuticals, cell targeting, cancer research, innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 1
Investor
21 Mar 2024
Series C •••••• 9
Investor Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		14 Nov 2023
Series B •••••• - 06 Nov 2017
Series A •••••• - 17 May 2016

Nouscom Alternatives & Competitors

Nouscom vs
Adiposs
Adiposs Switzerland

Imaging Body Fat - Saving Lives

Convertible Note
6 employees
Biotechnology
Compare Nouscom vs Adiposs
Nouscom vs
Likang Life Sciences
Likang Life Sciences China

Likang Life Sciences is an innovative enterprise dedicated to development of immune cell therapy, wi...

3 employees
Nouscom vs
CG Oncology
CG Oncology United States

Attacking Bladder Cancer for a Better Tomorrow

Series F
121 employees
Biotechnology, Health Care
Compare Nouscom vs CG Oncology
Also compare with: Nouscom vs Brenus Pharma Brenus Pharma

FAQ About Nouscom

Nouscom is a private clinical stage immuno-oncology company developing off-the-shelf and personalized cancer immunotherapies using proprietary viral vectors with demonstrated high immunogenicity in patients. Nouscom’s clinical pipeline includes NOUS-209, an off-the-shelf cancer immunotherapy assess...
Nouscom was founded in 2015.
Nouscom is headquartered in Switzerland.
Nouscom operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Nouscom has approximately 57 employees.
Nouscom has completed 4 funding rounds, raising a total of $128.50M. The latest funding stage is Series C.
Top alternatives and competitors to Nouscom include Adiposs, Likang Life Sciences, CG Oncology, Brenus Pharma, Ohana Vaccines, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nouscom and Adiposs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nouscom and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy